Ontario’s health-care system is putting Métis lives at risk—it’s time governments invest in research to influence meaningful change
Public policymakers and researchers need timely information that reflects the health-care needs of the Métis population.
Policy action is critical as Canada recognizes FASD Awareness Month
Advocates, medical experts, and those with lived experiences have for decades been calling on the federal government to take a leadership role.
Biotech
Biotechnology: an opportunity balanced on a knife’s edge
To fully harness the benefits of a thriving biotechnology industry, it is critical we act to address the challenges that threaten it.
Biotechnology must factor into a broader Canadian industrial policy
Governments should focus on supporting basic research, helping startups, and funding the scale-up of growth companies.
From crisis to catalyst: Canada’s opportunity to drive global health and research innovation
By creating an environment that fuels scientific advancement, Canada can face future crises with confidence, ensuring both its prosperity and global influence.
A flourishing biotech sector starts by innovating education
Innovating graduate education to support a wider variety of career paths will be key to creating the talent we need to have a vibrant biotechnology ecosystem.
The prescription for Canada’s health care future
Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
Biotechnology momentum in Canada needs infusion of talent and anchor firms, say industry reps
Canada has several prominent life science firms, but none can be considered an anchor company, according to a report by the adMare Institute released in late 2023.
Senate aims to serve up pharmacare for Thanksgiving
The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote on Oct. 10.
